This finding allows for a further understanding of the mechanism underlying the protective effects of HRS against AP and furthermore marks the NLRP3 inflammasome as a potential target for future therapeutic approaches of this dangerous disease. The gene discussed is NLRP3; the disease is alkaline phosphatase measurement.